ARMProgram.com Trend Top Navigation






Staphylococcus aureus (SOUTHEAST Data)
  2004 2005 2006 2007 2008 2009 2010
penicillin 9.1%
n=5952
9%
n=6156
8.1%
n=6135
9.2%
n=5906
10%
n=3401
18.1%
n=1158
12.2%
n=1207
amoxicillin/clavulanate 44.5%
n=4990
46.5%
n=3646
38.2%
n=4453
56.7%
n=910
98.7%
n=314
79.8%
n=838
49.7%
n=1053
ampicillin 7.8%
n=3452
8.9%
n=2676
9.3%
n=3116
14.5%
n=3701
9.1%
n=2375
9.5%
n=953
3%
n=967
ampicillin/sulbactam 97.5%
n=1361
56.9%
n=3830
60.7%
n=2115
61.9%
n=1779
67.6%
n=957
83%
n=993
49.3%
n=1051
nafcillin/oxacillin 56.8%
n=7957
47.2%
n=8647
44.6%
n=8779
43.5%
n=7399
52.5%
n=3856
83%
n=1016
54.5%
n=1211
vancomycin 100%
n=8015
100%
n=8864
100%
n=8717
100%
n=8359
100%
n=4016
100%
n=850
100%
n=896
quinupristin/dalfopristin 99.7%
n=2388
99%
n=572
100%
n=2499
99.9%
n=3615
 65.2%
n=606
87.9%
n=315
cefazolin 54.7%
n=7602
51.6%
n=6559
44.5%
n=8701
50.3%
n=5571
54.1%
n=3993
85.3%
n=1168
54.3%
n=1209
cefuroxime 45.1%
n=1595
36.2%
n=1809
36.1%
n=2649
38%
n=851
   
cefotaxime   96.2%
n=158
35.3%
n=600
 59.8%
n=423
 
ceftriaxone 69.5%
n=2973
56.1%
n=2648
42.1%
n=2913
50.3%
n=3655
49.7%
n=2382
83%
n=1003
49.7%
n=1053
cefepime 45.1%
n=1595
37.3%
n=2454
36.4%
n=2649
37.7%
n=2954
37%
n=944
59.6%
n=423
 
clindamycin 79.1%
n=6880
84.9%
n=3404
79.9%
n=5879
77.9%
n=6293
85.8%
n=2830
84.8%
n=528
86.4%
n=1086
erythromycin 37.6%
n=7957
31.2%
n=7983
31.1%
n=8213
29.6%
n=7311
35.6%
n=3294
48%
n=963
35.5%
n=1185
azithromycin  24%
n=1463
24.4%
n=2193
24%
n=851
   
ciprofloxacin 60.1%
n=2393
58.9%
n=3026
61.6%
n=3019
59.9%
n=3264
61.6%
n=2381
67.5%
n=656
46.1%
n=738
levofloxacin 58.5%
n=5075
61.6%
n=6102
65.1%
n=8075
62.5%
n=7632
65.7%
n=3120
72.6%
n=992
58.9%
n=1051
gatifloxacin 89.4%
n=472
89.6%
n=415
85.2%
n=427
83.4%
n=614
94.3%
n=244
  
moxifloxacin  95.5%
n=380
79.2%
n=1516
88.5%
n=546
96.1%
n=232
85.9%
n=348
87.6%
n=315
TMP/SMX 98.2%
n=7660
97.7%
n=7787
97.2%
n=8672
97.7%
n=8502
96.8%
n=4012
97.9%
n=1169
97.5%
n=1211
tetracycline 93.8%
n=4802
94.4%
n=7670
94.2%
n=8469
95%
n=8020
95.5%
n=3549
93.5%
n=783
93.6%
n=451
gentamicin 96.7%
n=6925
87%
n=5618
96.7%
n=8291
96.2%
n=7408
96.4%
n=3482
97.1%
n=729
96.8%
n=475
tobramycin   91.1%
n=45
    
amikacin  3.9%
n=536
     
meropenem  29.4%
n=572
   99.4%
n=324
100%
n=314
imipenem 40.3%
n=3272
37.5%
n=4727
34.8%
n=2635
32.6%
n=445
 77.7%
n=759
99.4%
n=315
pip/taz 100%
n=529
99.1%
n=572
 100%
n=211
 99.2%
n=256
 
rifampim 98.4%
n=7083
97.8%
n=6003
98.6%
n=7740
98.6%
n=7895
99.2%
n=3347
99.2%
n=1006
98.6%
n=1209
Totals67.1%
n=100928
62.2%
n=104119
64%
n=118058
67.5%
n=104292
67.2%
n=48729
74.3%
n=17944
61.8%
n=17312

This data is accurate as of: 11/22/2016 11:55:07 AM

Drugs with less than 10 isolates are removed from the chart and from the graph. The following drugs had some data removed: tobramycin.



Site Menu: Home Page | About ARM | Trends | Contact Us

University of Florida ARMProgram.com is a project run by the University of Florida.
Copyright 2011. All Rights Reserved.
Site by JMarc Technologies, LLC